<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03917212</url>
  </required_header>
  <id_info>
    <org_study_id>MITO-MRS</org_study_id>
    <nct_id>NCT03917212</nct_id>
  </id_info>
  <brief_title>Energy Metabolism in Branched-chain Organic Acidemias</brief_title>
  <official_title>Non-invasive Measurement of Energy Metabolism in Patients With Primary and Secondary Mitochondrial Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Children’s Hospital, Düsseldorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>German Diabetes Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Energy metabolism and insulin sensitivity were assessed in a case-control study in patients
      with branched-chain organic acidemias.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children and adults with branched-chain organic acidemias and matched healthy humans
      underwent deep metabolic phenotyping using non-invasive magnetic resonance spectroscopy, oral
      glucose tolerance tests and measurements of leucocyte respirometry in order to assess changes
      in energy metabolism and insulin sensitivity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2012</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hepatic and skeletal muscle energy metabolism</measure>
    <time_frame>At baseline</time_frame>
    <description>Hepatic and skeletal muscle energy metabolism assessed by magnetic resonance spectroscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>At baseline</time_frame>
    <description>Insulin sensitivity measured from oral glucose tolerance test</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">57</enrollment>
  <condition>Energy Metabolism</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Patients with propionic acidemia, isovaleric acidemia, methylmalonic acidemia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Healthy humans</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention, observational study with metabolic characterisation</description>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with known propionic acidemia, methylmalonic acidemia or isovaleric acidemia were
        enrolled as well as healthy humans of comparable age, sex and BMI
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  known branched-chain organic acidemia diagnosed by enzymatic or genetic test

          -  age&gt;5 years

        Exclusion Criteria:

          -  acute inflammatory conditions with fever, cold symptoms, gastro-intestinal infection
             within the last 24 hours

          -  contraindications for an oral glucose tolerance test such as fasting blood glucose
             &gt;126 mg/dl, severe chronic gastrointestinal conditions, allergy against black currant

          -  contraindications for magnetic resonance tomography (MRT) such as claustrophobia,
             metallic implants which are not MRT compatible
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Roden, Professeor</last_name>
    <role>Principal Investigator</role>
    <affiliation>German Diabetes Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Regina Ensenauer, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Düsseldorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of General Pediatrics, Neonatology and Pediatric Cardiology of the University Children's Hospital Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <state>NRW</state>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Clinical Diabetology, German Diabetes Center</name>
      <address>
        <city>Düsseldorf</city>
        <state>NRW</state>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 9, 2019</study_first_submitted>
  <study_first_submitted_qc>April 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>April 15, 2019</last_update_submitted>
  <last_update_submitted_qc>April 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Organic acidemias</keyword>
  <keyword>Mitochondria</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>Fatty liver</keyword>
  <keyword>Dyslipidemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

